勃起不全治療の世界市場-注目市場（2024年～2029年）

勃起不全（ED）とは、満足のいく性行為や性交を行うのに十分な陰茎の勃起を維持できない状態が持続または再発することです。EDは一般的にインポテンスと呼ばれ、最も一般的な男性の性的健康障害の1つと考えられています。

世界の勃起不全治療の市場規模は、2023年に47億2,751万米ドルと評価され、CAGRは-0.94％となりました。この市場規模は、主に勃起不全の有病率の上昇に起因しており、糖尿病、前立腺肥大症、前立腺がん、CVDなどの関連慢性疾患は、ひいては疾患発生の高リスク因子となる可能性があり、勃起不全治療市場の重要な要因となっています。

2023年には、北米と欧州がそれぞれ33.63％と29.05％の市場シェアで市場を独占しました。アジア太平洋はCAGR 2.70%で、予測期間中、収益面で最も急成長する勃起不全治療市場になると予想されます。

製品別では、医薬品分野が器具分野を圧倒し79.08%の市場シェアを占めたのに対し、器具分野は20.92%のシェアを占めました。しかし、予測期間中は、デバイスセグメントが2億5,258万米ドルと25.54%という最も高い増分成長率と絶対成長率を記録する可能性が高いです。

勃起不全治療薬の投与経路（RoA）セグメントは、経口薬、陰茎注射、局所薬に細分化されます。3つのサブセグメントのうち、経口薬が最大のシェアを占めているが、これはブランド薬の採用率が高いことに起因しています。全体では、経口薬が92.57％を占め、次いで陰茎注射薬が4.70％、外用薬が2.73％でした。

認知度の上昇、疾病の治療と管理のために医療支援を求める患者の意欲の高まり、勃起不全治療に薬剤や器具の使用を推奨する有利なガイドラインの存在感の高まりが、予測期間中の市場成長を促進すると予想されます。

当レポートでは、世界の勃起不全治療市場について調査し、市場の概要とともに、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 勃起不全治療市場概要

第2章 勃起不全治療市場

第3章 勃起不全治療市場セグメンテーションデータ

第4章 主要地域の概要

• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第5章 勃起不全治療市場の展望と機会

• 勃起不全治療市場の機会と動向
• 勃起不全治療市場促進要因
• 勃起不全治療市場の抑制要因

第6章 勃起不全治療業界の概要

• 勃起不全治療市場-競合情勢
• 勃起不全治療市場- 主要ベンダーのプロファイル
• 勃起不全治療市場- その他の著名なベンダー
• 勃起不全治療市場- 主要な戦略的推奨事項

第7章 付録

List Of Exhibits

LIST OF EXHIBITS

Exhibit 1: Projected Revenues of ED Treatment in Global (2023-2029; $ Mn)

Exhibit 2: Projected Revenue of ED Treatment by Drugs (2023-2029; $ Mn)

Exhibit 3: Projected Revenue of ED Treatment by Oral Drugs ($ Mn)

Exhibit 4: Projected Revenues of ED Treatment by Penile Injections (2023-2029; $ Mn)

Exhibit 5: Projected Revenues of ED Treatment by Topical Drugs (2023-2029; $ Mn)

Exhibit 6: Projected Revenues of ED Treatment by Retail Stores (2023-2029; $ Mn)

Exhibit 7: Projected Revenues of ED Treatment by Hospital Pharmacies (2023-2029; $ Mn)

Exhibit 8: Projected Revenues of ED Treatment by Online Portals (2023-2029; $ Mn)

Exhibit 9: Projected Revenue of ED Treatment by Devices (2023-2029; $ Mn)

Exhibit 10: Projected Revenues of ED Treatment by Penile Implants (2023-2029; $ Mn)

Exhibit 11: Projected Revenues of ED Treatment by Vacuum Construction Devices

(2023-2029; $ Mn)

Exhibit 12: Projected Revenues of ED Treatment by Shock Wave Therapy (2023-2029; $ Mn)

Exhibit 13: Projected Revenues of ED Treatment by Others (2023-2029; $ Mn)

Exhibit 14: Projected Revenues of ED Treatment in North America (2023-2029; $ Mn)

Exhibit 15: Projected Revenues of ED Treatment in US (2023-2029; $ Mn)

Exhibit 16: Projected Revenues of ED Treatment in Canada (2023-2029; $ Mn)

Exhibit 17: Projected Revenues of ED Treatment in Europe (2023-2029; $ Mn)

Exhibit 18: Projected Revenues of ED Treatment in UK (2023-2029; $ Mn)

Exhibit 19: Projected Revenues of ED Treatment in Germany (2023-2029; $ Mn)

Exhibit 20: Projected Revenues of ED Treatment in France (2023-2029; $ Mn)

Exhibit 21: Projected Revenues of ED Treatment in Italy (2023-2029; $ Mn)

Exhibit 22: Projected Revenues of ED Treatment in Spain (2023-2029; $ Mn)

Exhibit 23: Projected Revenues of ED Treatment in APAC (2023-2029; $ Mn)

Exhibit 24: Projected Revenues of ED Treatment in Japan (2023-2029; $ Mn)

Exhibit 25: Projected Revenues of ED Treatment in China (2023-2029; $ Mn)

Exhibit 26: Projected Revenues of ED Treatment in India (2023-2029; $ Mn)

Exhibit 27: Projected Revenues of ED Treatment in Latin America (2023-2029; $ Mn)

Exhibit 28: Projected Revenues of ED Treatment in Brazil (2023-2029; $ Mn)

Exhibit 29: Projected Revenues of ED Treatment in Mexico (2023-2029; $ Mn)

Exhibit 30: Projected Revenues of ED Treatment in Argentina (2023-2029; $ Mn)

Exhibit 31: Projected Revenues of ED Treatment in MEA (2023-2029; $ Mn)

Exhibit 32: Projected Revenues of ED Treatment in Saudi Arabia (2023-2029; $ Mn)

Exhibit 33: Projected Revenues of ED Treatment in South Africa (2023-2029; $ Mn)

Exhibit 34: Projected Revenues of ED Treatment in Turkey (2023-2029; $ Mn)

List Of Tables

LIST OF TABLES

Table 1: Key Market Trends in ED Treatment Market

Table 2: Key Market Enablers in ED Treatment Market

Table 3: Key Market Constraints in ED Treatment Market

Table 4: Strategic Recommendations in ED Treatment Market

REPORT OVERVIEW

This report offers market size & forecast data for the global erectile dysfunction treatment market. The revenue generated from the sale of drugs & devices is included in the report. This report provides a comprehensive and current market scenario of the global erectile dysfunction treatment market, including the global erectile dysfunction treatment market size, anticipated market forecast, relevant market segmentations, and industry trends.

The study considers a detailed scenario of the present global erectile dysfunction treatment market and its market dynamics for 2024-2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.

MARKET DEFINITION

Erectile dysfunction (ED) is the condition that is a persistent or recurrent inability to attain and maintain penile erection sufficient to permit satisfactory sexual activity and intercourse. ED is commonly referred to as impotence and is considered one of the most common male sexual health disorders.

KEY HIGHLIGHTS

• The global erectile dysfunction treatment market was valued at $4,727.51 million in 2023 and registered a negative CAGR of -0.94%. The market reach is mainly attributed to the rising prevalence of erectile dysfunction and associated chronic diseases such as diabetes, benign prostate hyperplasia, prostate cancer, and CVDs, which can, in turn, pose high-risk factors for the occurrence of disease, are critical factors for the erectile dysfunction treatment market.
• In 2023, North America and Europe dominated the market with a market share of 33.63% and 29.05%, respectively. APAC is expected to be the fastest-growing market for erectile dysfunction treatment in terms of revenue during the forecast period, with a CAGR of 2.70%.
• Based on product, the drugs segment dominated the market over the devices segment and accounted for a market share of 79.08%, whereas the devices segment accounted for a 20.92% share. However, during the forecast period, the devices segment will likely witness the highest incremental and absolute growth of $252.58 million and 25.54%, respectively.
• The route of administration (RoA) segment of ED drugs is sub-segmented into oral medications, penile injections, and topical drugs. Among the three sub-segments, oral drugs occupied the largest share, which is attributed to the high adoption of branded drugs. Overall, 92.57% was occupied by oral drugs, followed by penile injections at 4.70% and topical drugs at 2.73%.
• Rising awareness, growing patient willingness to demand medical assistance for disease care and management, and the increasing presence of favorable guidelines that recommend the use of drugs and devices for the treatment of ED are expected to propel the market growth during the forecast period.
• Bayer, Pfizer, Eli Lilly and Company, Coloplast, and Boston Scientific are some of the leading players currently dominating the global erectile dysfunction treatment market. The major players focus on strategic acquisitions and collaborations with emerging players to enter the ED treatment market and gain access to commercially launched products.

VENDORS LIST

• Bayer
• Pfizer
• Coloplast
• Eli Lilly and Company
• Boston Scientific
• Teva Pharma
• Viatris
• Dong-A Socio
• Vivus
• Cristalia
• Dr.Reddy's
• Aurobindo
• Seelos Therapeutics
• Menarini Group
• GSK plc
• Futura Medical
• Sanofi
• Cipla
• Lupin
• Advanz Pharma
• Sandoz
• IX Biopharma
• Domier Medtech
• Zephyr Surgical Implants
• Augusta Medical Systems
• Metuchen Pharmaceuticals
• SK Chemicals
• Endo International
• Ferring Pharmaceuticals
• Alembic Pharmaceuticals
• Guangzhou Pharmaceuticals
• Launch Medical
• Bonro Medical
• Owen Mumford
• Direx Group
• Zimmer Medizin Systems
• MTS Medical UG
• Medispec
• Inceler Medical
• NOVAmedtek
• Wikkon
• Top Quality Group
• Promedon
• Timm Medical Technologies
• Global Life Technologies
• Urology Health Store
• Hims

REPORT HIGHLIGHTS

PRODUCT SEGMENTATION & FORECAST

• Product type

Drugs

Route of Administration

• Oral Drugs
• Penile Injections
• Topical Drugs

Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Portals

Devices

Type

• Penile Implants
• Vacuum Construction Devices
• Shock Wave Therapy
• Others

MARKET STRUCTURE

• Market Dynamics
• Competitive Landscape of ED Treatment Market
• Key Vendors
• Other Prominent Vendors

APPENDIX

• Research Methodology
• Abbreviations
• About Arizton

TABLE OF CONTENTS

CHAPTER - 1: ED Treatment Market Overview

• Executive Summary
• Key Findings

CHAPTER - 2: ED Treatment Market

• GLOBAL: Projected Revenue of ED Treatment Market (2023-2029; $Millions)

CHAPTER - 3: ED Treatment Market Segmentation Data

• GLOBAL: Projected Revenue by Product type (2022-2028; $ Millions)

Drugs

Route of Administration

• Oral Drugs
• Penile Injections
• Topical Drugs

Distribution Channels

• Retail Stores
• Hospital Pharmacies
• Online Portals

Devices

Type

• Penile Implants
• Vacuum Construction Devices
• Shock Wave Therapy
• Others

CHAPTER - 4: Key Regions Overview

• North America: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
  • Projected Revenue of ED Treatment Market in US
  • Projected Revenue of ED Treatment Market in Canada
• Europe: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
  • Projected Revenue of ED Treatment Market in UK
  • Projected Revenue of ED Treatment Market in Germany
  • Projected Revenue of ED Treatment Market in France
  • Projected Revenue of ED Treatment Market in Italy
  • Projected Revenue of ED Treatment Market in Spain
• APAC: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
  • Projected Revenue of ED Treatment Market in Japan
  • Projected Revenue of ED Treatment Market in China
  • Projected Revenue of ED Treatment Market in India
• Latin America: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
  • Projected Revenue of ED Treatment Market in Brazil
  • Projected Revenue of ED Treatment Market in Mexico
  • Projected Revenue of ED Treatment Market in Argentina
• Middle East & Africa: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
  • Projected Revenue of ED Treatment Market in Saudi Arabia
  • Projected Revenue of ED Treatment Market in South Africa
  • Projected Revenue of ED Treatment Market in Turkey

CHAPTER - 5: ED Treatment Market Prospects & Opportunities

• ED Treatment Market Opportunities & Trends
• ED Treatment Market Drivers
• ED Treatment Market Constraints

CHAPTER - 6: ED Treatment Industry Overview

• ED Treatment Market - Competitive Landscape
• ED Treatment Market - Key Vendor Profiles
• ED Treatment Market - Other Prominent Vendors
• ED Treatment Market - Key Strategic Recommendations

CHAPTER - 7: Appendix

• Research Methodology
• Abbreviations
• About Arizton